The PolyPeptide Group is a privately-held Contract Development & Manufacturing Organization (CDMO) which focuses primarily on proprietary and generic GMP-grade peptides for the diagnostic, cosmetic, pharmaceutical and biotechnological market. The group has manufacturing facilities in Belgium, Sweden, France, India and two sites in the USA. As a multinational company with more than 950 employees worldwide, its diversity brings breadth and depth of knowledge and experience to the group. PolyPeptide has grown by selective acquisition of existing expertise, culminating in its position today as a leader in peptide manufacturing.